These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35664370)

  • 1. A Controlled Evaluation of a Sport-Specific Performance Optimization Program in an Athlete Diagnosed With Attention Deficit Hyperactivity Disorder and Oppositional Defiant Disorder Within the Context of COVID-19.
    Phrathep D; Donohue B; Kraus S; Paul M; Mercer J
    Clin Case Stud; 2022 Jun; 21(3):209-234. PubMed ID: 35664370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Psychosocial Outcome of Conduct and Oppositional Defiant Disorder in Children With Attention Deficit Hyperactivity Disorder.
    Eskander N
    Cureus; 2020 Aug; 12(8):e9521. PubMed ID: 32905151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
    Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap of ADHD and oppositional defiant disorder DSM-IV derived criteria.
    Ghanizadeh A
    Arch Iran Med; 2011 May; 14(3):179-82. PubMed ID: 21529106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P; Weizman A
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder with oppositional defiant disorder in Swedish children - an open study of collaborative problem solving.
    Johnson M; Ostlund S; Fransson G; Landgren M; Nasic S; Kadesjö B; Gillberg C; Fernell E
    Acta Paediatr; 2012 Jun; 101(6):624-30. PubMed ID: 22375727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sport and mental health performance optimization in an adolescent gymnast: A case evaluation.
    Phrathep D; Donohue B; Renn BN; Mercer J; Allen DN
    Front Sports Act Living; 2023; 5():1018861. PubMed ID: 36814896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifactor latent structure of attention-deficit/hyperactivity disorder (ADHD)/oppositional defiant disorder (ODD) symptoms and first-order latent structure of sluggish cognitive tempo symptoms.
    Lee S; Burns GL; Beauchaine TP; Becker SP
    Psychol Assess; 2016 Aug; 28(8):917-28. PubMed ID: 26502205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An open trial on effectiveness of parent training in children with comorbid attention deficit hyperactivity disorder and oppositional defiant disorder].
    Liu J; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):310-4. PubMed ID: 17572790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The attention deficit hyperactivity disorder phenotype as a summation of deficits in executive functioning and reward sensitivity: does this explain its relationship with oppositional defiant disorder?
    Poulton A; Nanan R
    Australas Psychiatry; 2014 Apr; 22(2):174-8. PubMed ID: 24402379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained Effects of Collaborative School-Home Intervention for Attention-Deficit/Hyperactivity Disorder Symptoms and Impairment.
    Pfiffner LJ; Rooney ME; Jiang Y; Haack LM; Beaulieu A; McBurnett K
    J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):245-251. PubMed ID: 29588050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Medical Society for Sports Medicine position statement: concussion in sport.
    Harmon KG; Drezner JA; Gammons M; Guskiewicz KM; Halstead M; Herring SA; Kutcher JS; Pana A; Putukian M; Roberts WO
    Br J Sports Med; 2013 Jan; 47(1):15-26. PubMed ID: 23243113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder.
    Garg J; Arun P; Chavan BS
    Int J Appl Basic Med Res; 2015; 5(2):114-8. PubMed ID: 26097819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.
    Biederman J; Spencer TJ; Newcorn JH; Gao H; Milton DR; Feldman PD; Witte MM
    Psychopharmacology (Berl); 2007 Jan; 190(1):31-41. PubMed ID: 17093981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.